Adaptive Biotechnologies
Translates a scale and precision of the adaptive immune system into products to diagnose and treat disease. Learn more
Launch date
Employees
Market cap
$680m
Enterprise valuation
$482m (Public information from Sep 2024)
Share price
$4.78 ADPT
Seattle Washington (HQ)
Authorizing premium user...